University of Macau
Wenhua ZHENG received his Bachelor's and Master's degree from Sun Yat-Sen University of Medical Sciences, China. He earned his Ph.D. from McGill University, Canada.
The alteration of signaling pathways (new biomarkers) in aging and degenerative disorders such as Alzheimer’s Disease and degenerative retinal diseases and identification of new biomarkers, the role of PI3K/Akt signaling pathway and FoxO transcription factors in aging and degenerative disorders and the identification of new functions and downstream targets of FoxO, New drug developments.
PJ Little.; MD Hollenberg.; D Kamato.; W Thomas.; J Chen.; T Wang.; Zheng W.; N Osman. Integrating the GPCR transactivation‐dependent and biased signalling paradigms in the context of PAR‐1 signalling. British journal of pharmacology 2015 Dec 1.
Wang H.; Xu J.; Chen J.; Peter J Little; Zheng W. Role of IGF-1 Signaling in the Pathology of Diabetic Retinopathy. Therapeutic Targets for Neurological Diseases 2015;2;1.
Chen Q.; Wang H.; Liao S.; Gao Y.; Liao R.; Little PJ.; Xu J.; Feng ZP.; Zheng Y.; Zheng W. Nerve growth factor protects retinal ganglion cells against injury induced by retinal ischemia-reperfusion in rats. Growth Factors 2015 Apr;33(2):149-59.